- Trials with a EudraCT protocol (126)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
126 result(s) found for: Brain Natriuretic Peptide.
Displaying page 1 of 7.
EudraCT Number: 2012-003921-13 | Sponsor Protocol Number: 12/0368 | Start Date*: 2013-06-07 | |||||||||||
Sponsor Name:University College London | |||||||||||||
Full Title: COMbination therapy for PulmonAry hypertension using RacEcadotril (COMPARE). | |||||||||||||
Medical condition: Pulmonary hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000727-17 | Sponsor Protocol Number: 281274 | Start Date*: 2007-08-23 | ||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Erasmus MC | ||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Maternal, uteroplacental and fetal haemodynamic effect of Nicardipine in severe pre-eclampsia. | ||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Hypertensive crisis in patients with severe pre-eclampsia needs to be treated to prevent maternal and fetal complications. The maternal, uteroplacental and fetal haemodynamic respose to antihypert... | ||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002207-15 | Sponsor Protocol Number: Cardiorete | Start Date*: 2011-12-27 |
Sponsor Name:FONDAZIONE DEL PIEMONTE PER L'ONCOLOGIA IRCC DI CANDIOLO | ||
Full Title: A prospective study with beta-blockers and ACE-inhibitors in patients operable breast cancer experiencing mild cardiac toxicity during treatment with anthracycline and/or trastuzumab | ||
Medical condition: patients experiencing mild cardiotoxicity during treatment with anthracycline and/or trastuzumab for operable breast cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-001131-31 | Sponsor Protocol Number: FHC-1-2012 | Start Date*: 2012-06-14 | |||||||||||
Sponsor Name:Department of Medical Research | |||||||||||||
Full Title: Effekts of nebivolol on the nitric oxide system in patients with essentiel hypertension | |||||||||||||
Medical condition: Essential Hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004207-22 | Sponsor Protocol Number: CLCZ696B2319 | Start Date*: 2017-04-06 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: Multicenter, open-label, study to evaluate safety, tolerability, pharmacokinetics and, pharmacodynamics of LCZ696 followed by a 52-week randomized, double-blind, parallel group, active-controlled s... | |||||||||||||
Medical condition: Pediatric heart failure 1 month to <18 years old | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) FI (Completed) NL (Ongoing) SE (Completed) NO (Completed) ES (Completed) GB (GB - no longer in EU/EEA) CZ (Completed) IT (Completed) FR (Completed) BG (Completed) PL (Completed) HU (Completed) HR (Completed) AT (Completed) PT (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-001636-60 | Sponsor Protocol Number: SL-3-2019 | Start Date*: 2019-07-12 | |||||||||||
Sponsor Name:University clinic of Nephrology and Hypertension, Regional Hospital Holstebro | |||||||||||||
Full Title: The effect of spironolactone on renal hemodynamics in patients with essential hypertension | |||||||||||||
Medical condition: Physiological responses in patients with essential hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003714-68 | Sponsor Protocol Number: 1744/2017 | Start Date*: 2017-11-15 | ||||||||||||||||
Sponsor Name:Medical University of Vienna | ||||||||||||||||||
Full Title: Effect of Supplemental Oxygen on Perioperative Brain Natriuretic Peptide Concentration in Cardiac Risk Patients - A prospective randomized clinical trial | ||||||||||||||||||
Medical condition: Evaluation of the effect of 80% versus 30% supplemental oxygen administration during major abdominal surgery on postoperative brain natriuretic peptide concentration. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-000667-40 | Sponsor Protocol Number: APD811-003 | Start Date*: 2015-04-23 | |||||||||||
Sponsor Name:Arena Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Randomized, Double-blind, Parallel-group, Placebo-controlled Phase 2 Trial of APD811, an Oral IP Receptor Agonist, in Patients with Pulmonary Arterial Hypertension | |||||||||||||
Medical condition: Pulmonary Arterial Hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) HU (Completed) ES (Completed) PL (Completed) RO (Ongoing) SK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003510-16 | Sponsor Protocol Number: EFC15156 | Start Date*: 2018-05-07 | ||||||||||||||||
Sponsor Name:Lexicon Pharmaceuticals, Inc. | ||||||||||||||||||
Full Title: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effects of Sotagliflozin on Clinical Outcomes in Hemodynamically Stable Patients with Type 2 Diabet... | ||||||||||||||||||
Medical condition: Cardiovascular diseases | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Completed) NL (Completed) ES (Prematurely Ended) LV (Completed) LT (Completed) GB (Completed) BE (Completed) DK (Prematurely Ended) FR (Completed) AT (Completed) CZ (Prematurely Ended) DE (Completed) SK (Completed) HU (Completed) FI (Completed) PT (Completed) GR (Completed) PL (Completed) IE (Completed) IT (Completed) RO (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-002960-27 | Sponsor Protocol Number: P-6708H | Start Date*: 2007-07-23 |
Sponsor Name:Pharma Nord ApS | ||
Full Title: Coenzyme Q10 as adjunctive treatment of chronic heart failure. A randomised double-blind multicenter trial with focus on Symptoms, Biomarker status (BNP) and long-term Outcome (hospitalisation/mort... | ||
Medical condition: Chronic heart failure for more than 6 weeks, in NYHA class III or IV. Age>18 years; males and females. Optimal medical treatment of heart failure according to the investigators opinion. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-001324-13 | Sponsor Protocol Number: 2007CV27 | Start Date*: 2007-05-23 | ||||||||||||||||
Sponsor Name:Research and Innovation Services, University of Dundee | ||||||||||||||||||
Full Title: Does Vitamin D improve markers of vascular health in stroke patients? | ||||||||||||||||||
Medical condition: Stroke (Ischaemic and haemorrhagic) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-002732-25 | Sponsor Protocol Number: 0105 | Start Date*: 2006-02-01 |
Sponsor Name:Geir Øystein Andersen, Department of Cardiology, Ulleval University Hospital | ||
Full Title: Safety and efficacy of levosimendan in patients with acute myocardial infarction complicated by symptomatic left ventricular failure | ||
Medical condition: Patients with acute myocardial infarction developing acute heart failure after primary PCI (percutaneus coronary intervention). Some patients in a predefined subgroup are categorized as patients in... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002614-12 | Sponsor Protocol Number: ESR-17-13447(DAPA-HF) | Start Date*: 2019-02-08 | |||||||||||
Sponsor Name:Instituto de Investigación Sanitaria INCLIVA | |||||||||||||
Full Title: Short-term Effects of Dapagliflozin on Peak VO2 in Patients with Heart Failure with Reduced Ejection Fraction and Type 2 Diabetes | |||||||||||||
Medical condition: Stable symptomatic heart failure with reduced ejection fraction (HFrEF) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-004398-76 | Sponsor Protocol Number: gjnh/mccormick/01 | Start Date*: 2006-03-22 |
Sponsor Name:Golden Jubilee National Hospital | ||
Full Title: A comparison of Myocardial Protection Using Preconditioning with Sevoflurane Against High Thoracic Epidural Analgesia for CABG Surgery | ||
Medical condition: Ischaemic heart disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2009-018125-70 | Sponsor Protocol Number: ENM-EA-016 | Start Date*: 2011-04-06 |
Sponsor Name:Medizinische Universität Graz | ||
Full Title: Styrian Vitamin D Hypertension Trial: A randomized, double-blind, placebo controlled trial to study the effects of vitamin D supplementation on systolic blood pressure in vitamin D deficient hypert... | ||
Medical condition: Patients with arterial hypertension and vitamin D deficiency | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-004014-16 | Sponsor Protocol Number: CSPP100A2313 | Start Date*: 2005-04-07 |
Sponsor Name:Novartis Pharma Services AG | ||
Full Title: A twelve-week, randomized, double-blind, multi-center, placebo controlled, parallel group study to evaluate the safety and efficacy of aliskiren 150 mg when added to standard therapy in patients wi... | ||
Medical condition: Hypertension | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) IT (Completed) DE (Completed) ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-000805-27 | Sponsor Protocol Number: MEIN/10/Ran-Did/001 | Start Date*: 2012-10-23 | |||||||||||
Sponsor Name:Menarini International Operations Luxembourg S.A., Avenue de la Gare, 1611 Luxembourg, Luxembourg | |||||||||||||
Full Title: Effect of Ranolazine in Heart Failure Patients with Preserved Ejection Fraction | |||||||||||||
Medical condition: Heart failure patients with preserved ejection fraction (HFpEF) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003818-24 | Sponsor Protocol Number: DC2015RED01 | Start Date*: 2015-12-11 |
Sponsor Name:VU University Medical Center | ||
Full Title: A phase 4, monocenter, randomized, double-blind, comparator-controlled, parallel-group, mechanistic intervention trial to assess the effect of 12-week treatment with the sodium-glucose linked trans... | ||
Medical condition: Type 2 Diabetes Mellitus | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-003404-39 | Sponsor Protocol Number: JBR-2-2013 | Start Date*: 2014-01-03 | |||||||||||
Sponsor Name:Department of Medical Research, Regional Hospital Holstebro | |||||||||||||
Full Title: The effect of sodium nitrite infusion on renal variables, brachial and central blood pressure during enzyme inhibition by allopurinol, enalapril or acetazolamid in healthy subjects. A randomized, d... | |||||||||||||
Medical condition: The normal physiological responses in healthy subjects | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001467-36 | Sponsor Protocol Number: FER-CARS-06 | Start Date*: 2017-02-02 | |||||||||||||||||||||
Sponsor Name:Vifor (International) Inc. | |||||||||||||||||||||||
Full Title: A Randomised, Double-blind Placebo Controlled Trial Comparing the Effect of Intravenous Ferric Carboxymaltose on Hospitalisations and Mortality in Iron Deficient Patients Admitted for Acute Heart F... | |||||||||||||||||||||||
Medical condition: Acute heart failure with iron deficiency | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) NL (Completed) PL (Completed) HR (Completed) SE (Completed) ES (Completed) IT (Completed) | |||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.